Close Menu
  • Home
  • AI
  • Education
  • Entertainment
  • Food Health
  • Health
  • Sports
  • Tech
  • Well Being

Subscribe to Updates

Subscribe to our newsletter and never miss our latest news

Subscribe my Newsletter for New Posts & tips Let's stay updated!

What's Hot

OpenClaw Creator Slams Europe’s Regulations As He Moves to the US

February 18, 2026

Perplexity Doubles Down on Subscriptions, Eyes Business Growth

February 18, 2026

Musk and OpenAI Posture Over Pizza As Talent War Heats up

February 17, 2026
Facebook X (Twitter) Instagram
  • Home
  • About Us
  • Advertise With Us
  • Contact us
  • DMCA
  • Privacy Policy
  • Terms & Conditions
Facebook X (Twitter) Instagram
IQ Times Media – Smart News for a Smarter YouIQ Times Media – Smart News for a Smarter You
  • Home
  • AI
  • Education
  • Entertainment
  • Food Health
  • Health
  • Sports
  • Tech
  • Well Being
IQ Times Media – Smart News for a Smarter YouIQ Times Media – Smart News for a Smarter You
Home » Texas sues Tylenol makers J&J and Kenvue, claiming they hid drug’s autism risks
Health

Texas sues Tylenol makers J&J and Kenvue, claiming they hid drug’s autism risks

IQ TIMES MEDIABy IQ TIMES MEDIAOctober 28, 2025No Comments1 Min Read
Facebook Twitter Pinterest LinkedIn Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email


(Reuters) -The makers of Tylenol, Johnson & Johnson and Kenvue, were sued on Tuesday by Texas Attorney General Ken Paxton, who accused them of knowingly hiding the drug’s links to autism and attention deficit hyperactivity disorder.

Paxton, a Republican, sued five weeks after Republican President Donald Trump said using Tylenol during pregnancy can cause autism in children. Trump is not a doctor, and his claim is unproven and not backed by scientific evidence.

Johnson & Johnson sold Tylenol for more than six decades, and its former Kenvue unit has sold it since 2023 after being spun off. The pain reliever is known generically as acetaminophen.

Kenvue has repeatedly defended Tylenol’s safety, and in a statement said it would defend against Paxton’s lawsuit.

“Acetaminophen is the safest pain reliever option for pregnant women as needed throughout their entire pregnancy,” Kenvue said. “We are deeply concerned by the perpetuation of misinformation on the safety of acetaminophen.”

In a separate statement, Johnson & Johnson did not comment on Paxton’s lawsuit, and said Kenvue is responsible for “all rights and liabilities associated with the sale of its over-the-counter products, including Tylenol.”

(Reporting by Jonathan Stempel in New York; Editing by Chizu Nomiyama)



Source link

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
IQ TIMES MEDIA
  • Website

Related Posts

FDA investigating Salmonella outbreak connected to moringa powder

February 17, 2026

Measles cases in South Carolina rise by 12 to 962, state health department says

February 17, 2026

A timeline of Rev. Jesse Jackson’s health issues, illnesses before his death

February 17, 2026
Add A Comment
Leave A Reply Cancel Reply

Editors Picks

Shooting at South Carolina dorm leaves 2 dead, suspect charged with murder

February 17, 2026

Hawaii Bill Would Turn Kids Into Published Authors At Kalihi Schools

February 17, 2026

Gov. Newsom expanded free preschool. Now private daycares say they can’t afford to stay open

February 17, 2026

Michigan wants schools ready for cardiac emergencies, fails to provide funds

February 17, 2026
Education

Shooting at South Carolina dorm leaves 2 dead, suspect charged with murder

By IQ TIMES MEDIAFebruary 17, 20260

COLUMBIA, S.C. (AP) — A man has been charged with murder after taking part in…

Hawaii Bill Would Turn Kids Into Published Authors At Kalihi Schools

February 17, 2026

Gov. Newsom expanded free preschool. Now private daycares say they can’t afford to stay open

February 17, 2026

Michigan wants schools ready for cardiac emergencies, fails to provide funds

February 17, 2026
IQ Times Media – Smart News for a Smarter You
Facebook X (Twitter) Instagram Pinterest Vimeo YouTube
  • Home
  • About Us
  • Advertise With Us
  • Contact us
  • DMCA
  • Privacy Policy
  • Terms & Conditions
© 2026 iqtimes. Designed by iqtimes.

Type above and press Enter to search. Press Esc to cancel.